|Articles|September 1, 2002

Enzyme converting DHEAS to DHEA deemed viable target for anti-acne drugdevelopment

Paris - Selective inhibition of the enzyme steroid sulfatase (STS)with a topically applied nonsteroidal compound may offer a novel approachto the treatment of acne, scientists from the Novartis Research Institute,Vienna, Austria, said at the World Congress of Dermatology.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME